Synthesis, conformational analysis and <i>in vivo</i> assays of an anti-cancer vaccine that features an unnatural antigen based on an sp<sup>2</sup>-iminosugar fragment
Iris A. Bermejo, Claudio D. Navo, J. Castro-López, Ana Guerreiro, Ester Jiménez‐Moreno, Elena M. Sánchez‐Fernández, Fayna García‐Martin, Hiroshi Hinou, Shin‐Ichiro Nishimura, José M. Garcı́a Fernández, Carmen Ortiz Mellet, Alberto Avenoza, Jesús H. Busto, Gonçalo J. L. Bernardes, Ramón Hurtado‐Guerrero, Jesús M. Peregrina, Francisco Corzana
Abstract
have proved that this vaccine elicits higher levels of specific anti-MUC1 IgG antibodies than the analog that bears the natural Tn antigen and that the elicited antibodies recognize human breast cancer cells with high selectivity. Altogether, we compile evidence to confirm that the presentation of the antigen, both in solution and in the bound state, plays a critical role in the efficacy of the designed cancer vaccines. Moreover, the outcomes derived from this vaccine prove that there is room for exploring further adjustments at the carbohydrate level that could contribute to designing more efficient cancer vaccines.